baber/WOPTO huggingface dataset:
Patent ES-2642181-B2 (ES)
Title: Colector para la flotación con espuma de minerales arcillosos a partir de menas de potasa
Inventor: GUSTAFFSON JAN OLAF
IPC: B03D103/10
Filed: 2015-11-18
Granted: 2018-07-13
Abstract: La invención se refiere a un procedimiento de flotación para la separación de lodos a partir de menas de potasa, en que se usa un colector que es una amina grasa propoxilada-etoxilada que tiene la fórmula#{IMAGEN-01}#en la que R1 es un grupo hidrocarbilo que tiene 8-24 átomos de C, la suma de todos los m es como media 2-6 y la suma de todos los n es como media al menos 15 y como máximo 100.
Patent AU-2001256496-B2 (AU)
Title: Synthetic process for the manufacture of an ecteinascidin compound
Inventor: PEREZ MARTA
IPC: A61K31/4995
Filed: 2001-05-15
Granted: 2006-02-16
Abstract: Preparation of an ecteinascidin product with a spiroamine-1,4-bridge involves forming a 1,4 bridge using a 1-labile, 10- hydroxy, 18-protected hydroxy, di-6,8-en-5-one fused ring compound. The C-18 protection is removed before spiroamine (preferably spiroquinoline) introduction. An independent claim is included for the manufacture of the ecteinascidin compound involving removing both protecting groups in a single step, according to the scheme. [Image] T : amino protecting group; and T' : hydroxy protecting group. ACTIVITY : Cytostatic. MECHANISM OF ACTION : None given.
Patent AU-2001273757-B2 (AU)
Title: Method and device for the suspended transport of objects on a transport track comprising an accumulated store
Inventor: MULLER ERWIN
IPC: B65H29/02
Filed: 2001-06-26
Granted: 2006-01-12
Abstract: Holding elements ( 1 ) equipped for transporting individual articles ( 2 ) in a held manner and being movable along a stretch of rail ( 5 ) independently of one another at least to a limited extent and having in pushed operation a regular minimum distance between one another, are banked-up during transportation at a banking-up point by a banking-up device ( 16 ) to form an accumulation store ( 12 ) upstream of the banking-up point. The holding elements are released in groups from the accumulation store ( 12 ) in a controlled manner and are conveyed away from the accumulation store. The holding elements ( 1 ) in the groups ( 15 ) advantageously are spaced the minimum distance from one another. For pre-forming the groups to be released ( 12 ) there is a further banking-up device ( 16 ) provided in the accumulation store ( 12 ). The further banking-up device acts at a further banking-up point upstream of the first banking-up point. The stream of groups being conveyed away from the accumulation store ( 12 ) can be supplied without any further transformation steps to a unit, in which the groups of articles held by holding elements ( 1 ) are processed (e.g. stacked and packed).
Patent AU-2001284606-B2 (AU)
Title: Perceptually improved encoding of acoustic signals
Inventor: BRUHN STEFAN
IPC: G10L21/02
Filed: 2001-09-07
Granted: 2007-01-25
Abstract: The present invention relates to encoding of an acoustic source signal (x) such that a corresponding signal (z/< ANd> ) reconstructed on basis of the encoded information has a perceptually high sound quality. The acoustic source signal (x) is encoded into at least one basic coded signal (P) by a coding arrangement in a transmitter (300). The at least one basic coded signal (P) thus represents perceptually significant characteristics of the acoustic signal (x). The coding arrangement in the transmitter (300) may include at least one spectral smoothing unit (305a), which receives at least one of the signal components on which the basic coded signal P is based and generates in response thereto a corresponding smoothed signal component. At least one enhanced coded signal P(E) is then produced from i.a. the corresponding smoothed signal component. The at least one enhanced coded signal P(E) thus constitutes a perceptually improved representation of the acoustic source signal (x), which is transmitted to a receiver (310) via a transmission medium (306). The receiver (310) receives at least one estimate (P/< ANd> E) of the transmitted signal(s) (P(E)). A spectral smoothing unit (305b) in the receiver (310) produces, on basis of a primary spectrum (Y/< ANd> ) decoded from the at least one received estimate (P/< ANd> E), a smoothed primary decoded spectrum (Y/< ANd> E). Finally, this signal (Y/< ANd> E) is used to generate an enhanced estimate (Z/< ANd> ) of the acoustic source signal (x). The at least one smoothed signal component respective the smoothed primary decoded spectrum (Y/< ANd> E) are produced by reducing a variation in coefficient values of the corresponding non-smoothed spectra representing frequency information above a threshold value (fT). <IMAGE>
Patent AU-2002222798-B2 (AU)
Title: Foam forming unit
Inventor: KELDERS JOHANNES HUBERTUS JOZE
IPC: B05B11/00
Filed: 2001-11-23
Granted: 2006-10-05
Abstract: A foam forming unit particularly suitable for a liquid container, comprising a pump for liquid and a pump for air, which are each provided with an inlet and an outlet, the foam forming unit further comprising a mixing chamber which is in communication with the outlet of each pump, a dispensing part provided with an outflow channel with a foam opening, the channel being in communication with the mixing chamber, and valves in respectively the inlet and the outlet of each pump for drawing in respectively delivering air and liquid, wherein one or more valves are formed integrally with the air pump or liquid pump into a single construction element.
Patent AU-2002226687-B2 (AU)
Title: Benzylamine analogue
Inventor: KOYAMA KAZUO
IPC: C07D487/04
Filed: 2002-01-22
Granted: 2005-08-25
Abstract: A compound of the formula (I): <CHEM> Äwherein R<1> represents a C1-C6 alkyl group etc., R<2> and R<3> are the same or different and represent a hydrogen atom etc., R<a> represents a C1-C6 alkyl group etc., Arom represents an aryl group etc., A represents a C1-C6 alkylene group, E represents a single bond, an oxygen atom, a sulfur atom etc., X<1> and X<2> are the same or different and represent an oxygen atom or a sulfur atomÜ or a pharmacologically acceptable salt or ester thereof.
Patent AU-2003238952-B2 (AU)
Title: Embossing method
Inventor: MCNEILL KEVIN B
IPC: B31F1/07
Filed: 2003-06-06
Granted: 2008-02-21
Abstract: Disclosed is an embossing method and material made by the method, including at least a pair of embossing rolls having unmatched embossing patterns engraved independently from each other, and having enlarged sidewall clearances between adjacent, inter-engaged protrusions and recessions of the embossing patterns. The sidewall clearances can range from about 0.002'' (about 0.050 mm) to about 0.050'' (about 1.27 mm). The width of the protrusions can be greater than about 0.002'' or about 0.050 mm. The peripheral surface of at least one of the embossing rolls can comprise a metal, a plastic, a ceramic, or a rubber. Also disclosed is an embossed web material capable of being used as a wrap material for food products, made by the above process.
Patent AU-2003245893-B2 (AU)
Title: Fiber reinforced filter for molten metal filtration and method for producing such filters
Inventor: JUMA KASSIM
IPC: B01D39/20
Filed: 2003-05-27
Granted: 2008-02-21
Abstract: The present invention relates to a fiber reinforced ceramic filter for molten metal filtration that comprises a bonded network of graphitized carbon and a method for producing such filters.
Patent AU-2003302361-B2 (AU)
Title: Derivatives of pyridinalkyl-amonoalkyl-1H-indole inhibiting receptors 5-HT and recapture of serotonin which can be used as antidepressant and anxiolitic
Inventor: BARTOSZYK GERD
IPC: C07D401/12
Filed: 2003-10-30
Granted: 2009-06-18
Abstract: Novel indole derivatives of the formula (I), in which X, Y, R<SUP>1</SUP>, R<SUP>1'</SUP>, m and n have the meanings indicated in Patent Claim 1, have a strong affinity to the 5-HT<SUB>1A </SUB>and in some cases to the 5-HT<SUB>1D </SUB>receptors. The compounds inhibit serotonin reuptake, exhibit serotonin-agonistic and -antagonistic properties and are suitable as antidepressants, anxiolytics and for the treatment of neurodegenerative diseases
Patent AU-2004223484-B2 (AU)
Title: Wave power assembly
Inventor: LEIJON MATS
IPC: F03B13/18
Filed: 2004-03-22
Granted: 2009-09-17
Abstract: A wave power assembly having a hull and a linear electric generator. The rotor is connected to the hull by connection means so that lifting force is transferred from the hull to the rotor. Spring means exert a force on the rotor that is counter-directed the lifting force. The spring means is arranged to, at a motion amplitude corresponding to 50% of the maximum length of stroke of the rotor, exert a force, the size of which varies by a factor of 2.5 as a maximum. The invention also relates to a wave power plant built up from wave power assemblies according to the invention. Furthermore, the invention relates to a use of the wave power assembly and a method for the generation of electric energy.
Patent AU-2004241202-B2 (AU)
Title: Rolling apparatus and method of making product of miscellaneous cross section with use of same
Inventor: TAMURA TAKASHI
IPC: F28D1/03
Filed: 2004-05-18
Granted: 2009-03-12
Abstract: A rolling apparatus including a first work roll and a second work roll cooperative with the first work roll for rolling a metal blank plate to manufacture a metal product of miscellaneous cross section including a plate portion having one side in the form of a flat surface and a plurality of ridges projecting upright from the other side of the plate portion integrally therewith and spaced from one another. The first work roll has a plurality of ridge forming annular grooves formed in the peripheral surface thereof over the entire circumference of the surface and arranged at a spacing axially of the first work roll. The two work rolls are rotated so that the peripheral speed of the bottom face of the deepest of all the ridge forming annular grooves in the first work roll is not less than the peripheral speed of the peripheral surface of the second work roll.
Patent AU-2004255457-B2 (AU)
Title: Non sticky gum base for chewing gum
Inventor: SOZZI GIUSEPPE
IPC: A23G4/00
Filed: 2004-07-06
Granted: 2008-03-13
Abstract: The present invention relates to a gum base formulation without polyvinyl acetate suitable for the production of a chewing gum with good sensory properties and good flavour release in combination with anti-adhesive properties in respect of teeth, dentures and the like typical of formulations containing polyvinyl acetate.
Patent AU-2004264570-B2 (AU)
Title: Method of monitoring glucose level
Inventor: FREGER DAVID
IPC: A61B5/00
Filed: 2004-08-09
Granted: 2009-04-23
Abstract: The method of monitoring or measuring the concentration of glucose level in human and animal blood uses a non-invasive technique and includes measurements of the speed of sound through the blood, the conductivity of the blood, and the heat capacity of the blood, or by non-invasive measurement of any other parameters that can be used to calculate the glucose level. Thereafter, the glucose level for each of the three measurements is calculated and the final glucose value is determined by a weighted average of the three calculated glucose values.
Patent AU-2004284185-B2 (AU)
Title: Sanitary ware fixtures
Inventor: HACKETT DONALD
IPC: E03C1/232
Filed: 2004-10-13
Granted: 2010-07-01
Abstract: A waste fitting for a basin, or similar item, comprising a first open end, a second open end and an inlet between the first and second ends. The waste fitting comprises a first seat for a plug, the inlet being located between the first seat and the second end, and a second seat for a plug, the second seat being located between the inlet and the second end. The inlet is connected in use to the overflow of the basin or similar item. With the plug in the second seat, the portion of the waste fitting above the plug, and the overflow system, may be filled with and may retain a cleaning or disinfecting product.
Patent AU-2004292371-B2 (AU)
Title: Pharmaceutical formulations for the sustained release of interleukins and therapeutic applications thereof
Inventor: MEYRUEIX REMI
IPC: A61K9/00
Filed: 2004-11-19
Granted: 2010-09-30
Abstract: A liquid pharmaceutical formulation (I) for prolonged release of interleukin(s) (IL) comprises a low viscosity aqueous colloidal suspension of submicron particles of water-soluble, biodegradable polymers (II) carrying hydrophobic groups, non-covalently associated with IL(s) and optionally other active agent(s), where on parenteral injection (I) forms a gelled depot for prolonging the duration of active agent release to more than 24 hours. A liquid pharmaceutical formulation (I) for prolonged release of interleukin(s) (IL) comprises a low viscosity aqueous colloidal suspension (with water as dispersion medium) based on submicron particles (SMP's) of water-soluble, biodegradable polymers (II) carrying hydrophobic groups (HG's), non-covalently associated with IL(s) and optionally other active agent(s). On parenteral injection, (I) forms a gelled depot in vivo (at least partially due to physiological proteins), controlling and prolonging the duration of active agent release to more than 24 hours. (I) is liquid under the injection conditions; at physiological temperature and/or pH; and/or in presence of physiological electrolytes at physiological concentrations and/or surfactant(s). Independent claims are included for: (1) a variant of (I) as described above, where the duration of release of active agents is not restricted but the concentration of (II) is sufficiently high to form a gelled depot in vivo in presence of protein(s) after parenteral injection; (2) novel derived products (preferably in powder or gel form), consisting of SMP's formed by non-covalent association of (II) and active agents as above and obtained from (I); and (3) methods of preparation of (I). ACTIVITY : Antiinflammatory; immunomodulator. MECHANISM OF ACTION : T-Lymphocyte activator; T-lymphocyte proliferation profieration inducer.
Patent AU-2004315258-B2 (AU)
Title: Fluid supply assembly for spray guns with cup and lid comprising mating flanges
Inventor: KOSMYNA MICHAEL J
IPC: B05B7/24
Filed: 2004-11-23
Granted: 2009-04-02
Abstract: A fluid supply assembly. The fluid supply assembly includes a disposable cup and lid, and a reusable cup holder and outer lid.
Patent AU-2004316447-B2 (AU)
Title: Pressure control device
Inventor: SWIETEN ROY VAN
IPC: B65D83/14
Filed: 2004-08-05
Granted: 2010-04-22
Abstract: The invention is a pressurized gas providing and gas pressure regulating device. The invention is a container with an over pressurized second chamber of pressurized gas that can be released to the exterior of the container when a valve that is integrally connected to a piston that along with a first cylinder forms a first chamber that is filled with a comparably less over pressurized gas that pushes the valve open when the gas pressure outside of the container is too low, thereby permitting the over pressurized second chamber to fluidly connect via the valve and thereby increase the pressure outside the container, such as to a volume of gas located below a piston within a fluid dispenser, the first and second chambers are shaped as cylinders and the first cylinder fits within the second chamber.
Patent AU-2005205188-B2 (AU)
Title: Biochemical synthesis of 6-amino caproic acid
Inventor: PEETERS WIJNAND PETER HELENA
IPC: C12P13/02
Filed: 2005-01-17
Granted: 2010-11-11
Abstract: The invention relates to biochemical synthesis of 6-amino caproic acid from 6-aminohex-2-enoic acid compound or from 6-amino-2-hydroxyhexanoic acid, by treatment with an enzyme having ±,²-enoate reductase activity towards molecules containing an ±,²-enoate group and a primary amino group.  The invention also relates to processes for obtaining suitable genetically engineered cells for being used in such biotransformation process, and to precursor fermentation of 6-amino caproic acid from intermediates leading to 6-amino caproic acid.  Finally, the invention relates to certain novel biochemically produced compounds, namely 6-aminohex-2-enoic acid, 6-aminohexanoic acid, as well as to caprolactam produced therefrom and to nylon-6 and other derivatives produced from such biochemically produced compounds or caprolactam.
Patent AU-2005251558-B2 (AU)
Title: Blood vessel occlusion auger
Inventor: SHAMAY NOAM
IPC: A61M39/00
Filed: 2005-06-08
Granted: 2011-03-31
Abstract: A blood occlusion auger having an in vivo distal auger tool coupled in operative association with an ex vivo auger control for opening and traversing occlusions in a blood vessel The auger control allows the selection of predetermined threshold forces and step-lengths values and operates in successive repetition of identical sequential stages, to traverse occlusions. Once disposed adjacent an occlusion, the auger tool, commanded by the auger control, operates in two states, first to radially dilate the vessel and second to penetrate distally into a furrow.
Patent AU-2005254807-B2 (AU)
Title: Thymidine kinase
Inventor: STEFANIA MASSA
IPC: C12N9/12
Filed: 2005-06-17
Granted: 2011-08-18
Abstract: A polynucleotide comprising a nucleotide sequence encoding a thymidine kinase wherein at least one of the nucleotides corresponding to the splice donor site nucleotides is replaced by another nucleotide and wherein the nucleotides of the splice acceptor sites are not altered.
Patent AU-2005259030-B2 (AU)
Title: Process for the removal of selectable marker gene sequences
Inventor: BLOOR ALEXANDRA ELIZABETH
IPC: C12N15/867
Filed: 2005-07-01
Granted: 2010-08-19
Abstract: The invention relates to a process for the removal of selectable marker gene sequences, in particular antibiotic gene sequences, from nucleic acid molecules. The invention further relates to the application of this process in the unlabelled integration and deletion of chromosomal genes and in controlling gene expression.
Patent AU-2006237354-B2 (AU)
Title: Dihydrothienopyrimidines for the treatment of inflammatory diseases
Inventor: POUZET PASCALE
IPC: C07D495/04
Filed: 2006-04-19
Granted: 2012-03-01
Abstract: The invention relates to novel dihydrothienopyrimidines of formula (1) as well as pharmaceutically acceptable salts, diastereomers, enantiomers, racemates, hydrates, or solvates thereof, which are suitable for the treatment of ailments or diseases of the respiratory tract, gastrointestinal ailments or diseases, inflammatory diseases of the joints, skin, or eyes, diseases of the peripheral or central nervous system, or cancer diseases. Also disclosed are pharmaceutical compositions containing the inventive compounds.
Patent AU-2006270662-B2 (AU)
Title: A composition comprising an extract of tiarella polyphylla and tiarellic acid isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity
Inventor: HEE KIM JUNG
IPC: A23L33/00
Filed: 2006-07-18
Granted: 2011-08-25
Abstract: The present invention relates to a composition comprising an extract of Tiarella polyphylla, and tiarellic acid isolated therefrom having anti-inflammatory, anti-allergic and anti-asthmatic activity. The extract of Tiarella polyphylla and the tiarellic acid isolated therefrom shows the inhibitory effect on the LTC release in vitro test and the suppressive effect on the IgE level and the cytokine(IL-4, IL-5 and IL- 13) production, airway hyperresponsiveness, and leukocyte infiltration in OVA-induced asthmatic mice. Therefore, it can be used as the therapeutics or functional health food for treating and preventing inflammatory, allergic and asthmatic disease.
Patent AU-2006311803-B2 (AU)
Title: Use of complement pathway inhibitors to treat ocular diseases
Inventor: YAO ZHENGBIN
IPC: A61K38/00
Filed: 2006-11-04
Granted: 2012-11-01
Abstract: The present invention relates to the treatment of ocular diseases and conditions by administering a complement pathway inhibitor, particularly an alternative pathway inhibitor. Ocular diseases include age-related macular degeneration, diabetic retinopathy, and ocular angiogenesis. One embodiment comprises the administration of an anti-Factor D antibody in the form of a whole antibody, a Fab fragment or a single domain antibody. Other complement component inhibitors that may be useful in the present method include Factor H or inhibitors that block the action of properdin, factor B, factor Ba, factor Bb, C2, C2a, C3a, C5, C5a, C5b, C6, C7, C8, C9, or C5b-9.
Patent AU-2006333519-B2 (AU)
Title: Diffusion-hardened medical implant
Inventor: JANI SHILESH C
IPC: A61F2/28
Filed: 2006-11-10
Granted: 2013-08-15
Abstract: The present invention relates to a new composition and medical implant made therefrom, the composition comprising a thick diffusion hardened zone, and preferably further comprising a ceramic layer. The present invention relates to orthopedic implants comprising the new composition, methods of making the new composition, and methods of making orthopedic implants comprising the new composition.
Patent AU-2006339505-B2 (AU)
Title: Chair stabilizer for refractive surgery
Inventor: MARK BRINKERHOFF
IPC: A61G15/02
Filed: 2006-12-20
Granted: 2011-07-07
Abstract: Devices, systems, and methods for supporting and/or stabilizing a patient can help to position a patient relative to a therapeutic laser beam, for example, inhibiting motion or deflection during a refractive procedure on the eyes, and the like. A stabilizing structural member can support a chair or other patient support near shoulders of the patient, and the member may remain stationary while the chair is driven in a horizontal plane by a linkage. Often, a nominal patient center of gravity is located between the support member and a portion of the patient support which is supported by the linkage to reduce cantilever effects. The member may be rigidly attached to a vertical motion stage which moves the chair at an angle, for example at an angle normal to the horizontal plane.
Patent AU-2007201217-B2 (AU)
Title: Ion detection system with neutral noise suppression
Inventor: HOSEA KIKI H
IPC: H01J43/10
Filed: 2007-03-20
Granted: 2013-06-20
Abstract: An ion detection system includes a mass analyser generating an ion beam along an ion beam longitudinal axis. A field generator generates a field for altering the direction of ions in the ion beam away from the ion beam longitudinal axis. A conversion dynode includes an ion collision region on a conversion dynode surface. A conversion dynode axis passes through the ion collision region perpendicular to the conversion dynode surface, the conversion dynode axis being offset from and not intersecting the ion beam longitudinal axis. An electron multiplier receives secondary charged particles from the conversion dynode generated in response to the ion collision with the conversion dynode surface. ___ 3.6 4.2 3. 3.93. N orS 3.2 ~S or N 3.13. 3. 4 PF 5.3 4.6 t
Patent AU-2007317446-B2 (AU)
Title: Patient information management system
Inventor: BARKER BOB
IPC: A61B5/00
Filed: 2007-11-01
Granted: 2013-09-05
Abstract: A computer-implemented system (10) for patient information management, including at least one database (20) having a plurality of data fields populated with patient data, clinician data, physician data, healthcare provider data, device data, medical data, health data, presentation data, identification data, administrator data, or any combination thereof. The system provides a patient information interface (12) in communication with the at least one database for selectively and dynamically presenting data fields to the users that are configured for access to the interface. A set of program instructions is configured to facilitate communication of data between at least one patient device and the system. A communication for patient information management and a method of facilitating the secure transmission of data of a patient device over a network to a patient management system are also disclosed.